One of The Myeloma Beacon's most popular news stories of 2011 reported on an important new devel­op­ment in the use of gene ther­apy to treat blood cancers.

In particular, the article described promising results from a small study using gene ther­apy to treat patients who have chronic lymphocytic leukemia (CLL), and it looked at how those results might translate into new ther­a­pies for multiple myeloma (see related Beacon news).

Since the results of the CLL study were made public last year, follow-up results and addi­tional ongoing studies further indicate …

A promising experimental method for treating ad­vanced leukemia may point the way to important new treat­ment options for multiple myeloma.

“It is very exciting,” said Dr. Leif Bergsagel, a myeloma specialist from the Mayo Clinic in Arizona who was not involved in the study investigating the leukemia treat­ment. “I think this ap­proach could and should be extended to multiple myeloma.”  He pointed out, however, that “It will be several years before myeloma patients will be treated this way.”

In two recently published research articles, scientists from the University of Pennsylvania described initial results of a pilot study they are conducting.  The results …

This article is the fifth in a five-part series about emerging vaccines for multiple myeloma. It tells the story of a patient who participated in a myeloma vaccine clinical trial.  The first article in the series provides an introduction to the concept of a myeloma vaccine, the second article provides an introduction to the various types of myeloma vaccines that are currently under development, the third article describes vaccines for which clinical trials have been completed, and the fourth article focuses on ongoing myeloma vaccine research.

Tom Liebert …

This article is the fourth in a five-part series about emerging vaccines for multiple myeloma. It focuses on ongoing myeloma vaccine research.  The first article in the series provides an introduction to the of a myeloma vaccine, the second article provides an introduction to the various types of myeloma vaccines that are currently under development, and the third article describes vaccines for which clinical trials have been completed.  The fifth article tells the story of a patient who participated in a myeloma vaccine clinical trial.

Vaccine therapy …

This article is the third in a five-part series about emerging vaccines for multiple myeloma. It describes vaccines for which clinical trials have been completed. The first article in the series provides an introduction to the concept of a myeloma vaccine, and the second article provides an introduction to the various types of myeloma vaccines that are currently under development. The fourth article focuses on ongoing vaccine research, and the fifth article tells the story of a patient who participated in a myeloma vaccine clinical trial.

Clinical trials …

This article is the second in a five-part series about emerging vaccines for multiple myeloma.  It provides an introduction to the various types of vaccines that are currently under development for myeloma.  The first article in the series provided an introduction to the concept of a myeloma vaccine. The third article describes vaccines for which clinical trials have been completed, the fourth article focuses on ongoing vaccine research, and the fifth article tells the story of a patient who participated in a myeloma vaccine clinical trial.

As …

This article is the first in a five-part series about emerging vaccines for multiple myeloma.  It provides an introduction to the concept of a myeloma vaccine.  The second article provides an introduction to the various types of vaccines that are currently under development for myeloma, the third article describes vaccines for which clinical trials have been completed, the fourth article focuses on ongoing vaccine research, and the fifth article tells the story of a patient who participated in a myeloma vaccine clinical trial.

A Search For The …